Influenza Vaccine (Split Virion) (Jiangsu Wosen Bio-Technology)

流感病毒裂解疫苗（江苏沃森生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza Vaccine (Split Virion) (Jiangsu Wosen Bio-Technology)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesJiangsu Huanuotai Biomedical Technology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Huanuotai Biomedical Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A